The synthetic organic chemistry described in this section forms a basis for the research projects described by other members of the Program. A fundamental objective is the synthesis of a series of modified DNA nucleosides that will be incorporated site-specifically into oligonucleotides using automated, solid-state methods. The modified deoxynucleosides selected for study fall into two classes. The first group is related to our investigations on oxidative DNA damage. These substances will be used (a) to construct affinity chromatography substrates for the purification and isolation of DNA repair enzymes (MutM and MutY proteins) that deal with oxidative lesions and (b) to study the mechanisms of action of these enzymes (principally MutY) in the repair process. The second group of deoxynucleosides have modifications related to carcinogenic amines and nitro compounds. They are subdivided into two classes: (a) those that relate to C8-dG adducts and (b) those that rise by attack of the ultimate carcinogen on the N2-position of deoxyguanosine. These defined adducts will be used to establish the mutagenic spectrum generated by the original carcinogen. In addition, they should aid in the solution of structural problems associated both with the nucleosides themselves and with oligomeric DNA containing them. For these purposes, 13C and 15N-labeled nucleosides will be synthesized. Research on the use of new protecting groups for DNA synthesis also will be pursued. This should allow otherwise difficult post-synthetic introduction of base-sensitive lesions into DNA. Analytical studies will investigate the formation of new oxidation products, including cross- linked deoxynucleoside dimers whose structure has not been characterized, and will establish accurate, sensitive assays for oxidation products derived from nuclear and mitochondrial DNA.

Agency
National Institute of Health (NIH)
Institute
National Institute of Environmental Health Sciences (NIEHS)
Type
Research Program Projects (P01)
Project #
5P01ES004068-10
Application #
5211089
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
10
Fiscal Year
1996
Total Cost
Indirect Cost
Yun, Byeong Hwa; Guo, Jingshu; Turesky, Robert J (2018) Formalin-Fixed Paraffin-Embedded Tissues-An Untapped Biospecimen for Biomonitoring DNA Adducts by Mass Spectrometry. Toxics 6:
Jelakovi?, Bojan; Vukovi? Lela, Ivana; Karanovi?, Sandra et al. (2015) Chronic dietary exposure to aristolochic acid and kidney function in native farmers from a Croatian endemic area and Bosnian immigrants. Clin J Am Soc Nephrol 10:215-23
Romanov, Victor; Whyard, Terry C; Waltzer, Wayne C et al. (2015) Aristolochic acid-induced apoptosis and G2 cell cycle arrest depends on ROS generation and MAP kinases activation. Arch Toxicol 89:47-56
Yun, Byeong Hwa; Sidorenko, Viktoriya S; Rosenquist, Thomas A et al. (2015) New Approaches for Biomonitoring Exposure to the Human Carcinogen Aristolochic Acid. Toxicol Res (Camb) 4:763-776
Castells, Xavier; Karanovi?, Sandra; Ardin, Maude et al. (2015) Low-Coverage Exome Sequencing Screen in Formalin-Fixed Paraffin-Embedded Tumors Reveals Evidence of Exposure to Carcinogenic Aristolochic Acid. Cancer Epidemiol Biomarkers Prev 24:1873-81
Jelakovi?, Bojan; Nikoli?, Jovan; Radovanovi?, Zoran et al. (2014) Consensus statement on screening, diagnosis, classification and treatment of endemic (Balkan) nephropathy. Nephrol Dial Transplant 29:2020-7
Ivkovi?, Vanja; Karanovi?, Sandra; Fištrek Prli?, Margareta et al. (2014) Is herbal tea consumption a factor in endemic nephropathy? Eur J Epidemiol 29:221-4
Yun, Byeong Hwa; Yao, Lihua; Jelakovi?, Bojan et al. (2014) Formalin-fixed paraffin-embedded tissue as a source for quantitation of carcinogen DNA adducts: aristolochic acid as a prototype carcinogen. Carcinogenesis 35:2055-61
Attaluri, Sivaprasad; Iden, Charles R; Bonala, Radha R et al. (2014) Total synthesis of the aristolochic acids, their major metabolites, and related compounds. Chem Res Toxicol 27:1236-42
Sidorenko, Viktoriya S; Attaluri, Sivaprasad; Zaitseva, Irina et al. (2014) Bioactivation of the human carcinogen aristolochic acid. Carcinogenesis 35:1814-22

Showing the most recent 10 out of 136 publications